To better understand the impact of SARS-CoV-2 infection in patients displaying innate immunity disorders such as familial Mediterranean fever (FMF), a team of eight French researchers surveyed 342 FMF patients on SARS-CoV-2 infection between March and May 2020. The study focused on 27 FMF patients who had COVID symptoms. Out of the 27 FMF-COVID+ patients: